From @Breakingviews: The biotech sector has been immune to U.S.-China tensions that sickened cross-border tech investments; in fact, rising stars like BeiGene are thriving. Decoupling looks unlikely, but political risks are rising fast, says @mak_robyn https://t.co/rsFtKp6y53 pic.twitter.com/TJGSvWK3pH— Reuters (@Reuters) January 12, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


